Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer
Clinical trial NCT00667862 · COMPLETED
Trial details
- NCT number
- NCT00667862
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-18
- Primary completion
- 2010-11-05
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.